Gregory Stock is a biophysicist, best-selling science writer, and the director of the Program on Medicine, Technology, and Society at UCLA’s School of Public Health. He has often focused on the implications for society, medicine, and business of the human genome project and associated developments in molecular genetics and bioinformatics.
Stock is also the CEO of Signum Biosciences, a biotech company developing therapeutics for Alzheimer’s disease, sits on the editorial board of the American Journal of Bioethics, and is a professor in the Department of Psychiatry and Biobehavior at UCLA.
His book “Redesigning Humans: Our Inevitable Genetic Future” (2002) won the Kistler Book Prize for Science books and was nominated for a Wired Rave Award.
Source - Wikipedia http://en.wikipedia.org/wiki/Gregory_Stock